Resource Central is a product of the Pediatric Pandemic Network.

Nirsevimab Library

This is a collection of current resources related to Nirsevimab.

Estimates: Nirsevimab 89% Effective Against RSV in Kids, 93% Against Hospitalization
2024 · University of Minnesota
This news brief describes the effectiveness of nirsevimab, a monoclonal antibody drug, in protecting children under 5 from RSV. The drug is 89% effective against …
Studies Show More Promising Results for RSV Drug Nirsevimab
2024 · University of Minnesota
This blog post describes two studies showing that the RSV drug nirsevimab is effective in protecting infants from respiratory syncytial virus. The first study found …

Looking for different way to find resources?

Our chatbot aRCie can help with a more personalized search. Click below to try our new chatbot.

Try aRCie